Patents by Inventor Jason McKeown

Jason McKeown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220218980
    Abstract: Methods, systems and devices are provided to stimulate the vestibular system in such a way as to alleviate post-infection symptoms of COVID-19. A device with one or more electrodes placed over a subject's scalp provides vestibular nerve stimulation (VeNS) to the vestibular nerve, which is then carried into the vestibular nucleus in the brainstem to alleviate post-infection symptoms of COVID-19 related to the vestibular system, including dizziness, fatigue, malaise, headache, nerve pain, insomnia and sleep problems, anxiety, depression and difficulty concentrating. The characteristics of the stimulation signal and duration of the treatment are configured to allow the treatment to be delivered at the onset of one or more symptoms or at regular daily intervals alleviate the post-infection symptoms immediately or over a longer period of time.
    Type: Application
    Filed: March 31, 2022
    Publication date: July 14, 2022
    Inventors: Jason McKeown, Paul Duncan McGeoch
  • Publication number: 20210290958
    Abstract: Methods, systems and devices are provided to stimulate the vestibular system in such a way as to influence the neurological components of the autonomic nervous system and reduce an anxiety level in a subject. A device with one or more electrodes placed over a subject's scalp provides vestibular nerve stimulation (VeNS) to the vestibular nerve, which is then carried into the vestibular nucleus in the brainstem and thereafter transmitted to the neurological components of the autonomic nervous system to reduce a physiological reaction to an anxiety event. The characteristics of the stimulation signal and duration of the treatment are configured to allow the treatment to be delivered before, during or after an anxiety event to potentially prevent or at the very least reduce an anxiety response in the subject.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 23, 2021
    Applicant: NEUROVALENS, LTD.
    Inventor: Jason McKeown
  • Publication number: 20210046312
    Abstract: Methods, systems and devices are provided for synchronous, binaural vestibular stimulation with two linked vestibular stimulators positioned on or around a subject's left and right mastoid processes and synchronized to deliver vestibular stimulation simultaneously to each of a patient's vestibular nerves. Each vestibular stimulator contains both an anode and cathode in order to create a localized, circular flow of current at each stimulation site to provide a localized, circular flow of current at each of the subject's mastoid processes and adjacent vestibular nerves. By communicating between the vestibular stimulators—either via a wired or wireless connection—the vestibular stimulation can be provided simultaneously at each site, eliminating the rocking sensation that results from delivering stimulation across a patient's head from the cathode on one side of the head to the anode on the opposing side of the head.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Applicant: NEUROVALENS, LTD.
    Inventor: Jason McKeown
  • Publication number: 20200360653
    Abstract: Methods, systems and devices are provided to stimulate the vestibular system in such a way as to excite the neurological components of the circadian rhythm system and induce sleep. A device with one or more electrodes placed over a subject's scalp provides vestibular nerve stimulation (VeNS) to the vestibular nerve, which is then carried into the vestibular nucleus in the brainstem and thereafter transmitted to the neurological components of the circadian rhythm system to excite the areas that promote sleep, allowing the body to enter the sleep state. The characteristics of the stimulation signal and duration of the treatment are configured to allow the treatment to be delivered in advance of the subject's desired sleep time so that the device does not need to be worn in bed.
    Type: Application
    Filed: May 4, 2020
    Publication date: November 19, 2020
    Inventor: Jason McKeown
  • Patent number: D844159
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: March 26, 2019
    Assignee: Neurovalens Ltd.
    Inventor: Jason McKeown